| AAV | ANCA-associated vasculitis |
| ACS | Angiographic Composite Score |
| ADS | Angiographic Dilatation Score |
| AGATA | Abatacept in Giant Cell Arteritis and Takayasu arteritis |
| ANCA | Antineutrophil cytoplasmic antibody |
| APRs | Acute phase reactants |
| ASS | Angiographic Stenosis Score |
| AUC | Area under the curve |
| BVAS | Birmingham Vasculitis Activity Score |
| CA125 | Cancer antigen 125 |
| CA15-3 | Cancer antigen 15-3 |
| CARDS | Combined Arteritis Damage Score |
| CCL | Chemokine (C-C motif) ligand |
| CDUS | Colour Doppler ultrasound |
| CDUS-K | Colour Doppler ultrasound in Takayasu arteritis score from Kolkata |
| CDA | Combined Damage Assessment Index |
| CECs | Circulating endothelial cells |
| CEMRA | Contrast-enhanced MRA |
| CRP | C-reactive protein |
| CTA | Computerized tomographic angiography |
| C4BP | C4 binding protein |
| DEI.TAK | Disease Extent Index in TAK |
| DMARDs | Disease-modifying anti-rheumatic drugs |
| DSA | Digital subtraction angiography |
| EPCs | Endothelial progenitor cells |
| ESR | Erythrocyte sedimentation rate |
| EULAR | European Alliance of Associations for Rheumatology |
| FAPI | Fibroblast Activator Protein Inhibitor |
| 18-FDG | 18-fluorodeoxyglucose |
| GCA | Giant cell arteritis |
| GFR | Glomerular filtration rate |
| GROα | Growth-regulated oncogene α |
| IGFBP-2 | Insulin like growth factor binding protein 2 |
| IL | Interleukin |
| ICAM-1 | Intercellular adhesion molecule 1 |
| ITAS | Indian TAK Clinical Activity Score |
| LVV | Large vessel vasculitis |
| LYVE-1 | Lymphatic vessel endothelial hyaluronan receptor 1 |
| MRA | Magnetic resonance angiography |
| MMPs | Matrix metalloproteinases |
| MRP 8/14 | Myeloid-related protein 8/14 |
| NLR | Neutrophil-to-lymphocyte ratio |
| PAAT | Periaortic adipose tissue |
| PCAT | Pericoronary adipose tissue |
| PETVAS | PET vascular activity score |
| PET-CT | Positron emission tomography computerized tomography |
| PET-MRI | PET-magnetic resonance imaging |
| PGA | Physician global assessment |
| PLR | Platelet-to-lymphocyte ratio |
| PROMs | Patient-reported outcome measures |
| PTX-3 | Pentraxin-related protein |
| RAG-1 | Recombination activating gene 1 |
| RCTs | Randomized controlled trials |
| RDW | Red cell distribution width |
| SAA | Serum amyloid A |
| SAP | Serum amyloid P |
| SNPs | Single nucleotide polymorphisms |
| SST2 | Somatostatin receptor subtype 2 |
| SUVmax | Maximum standardized uptake values |
| SUVmean | Mean standardized uptake values |
| TADS | Takayasu Arteritis Damage Score |
| TAK | Takayasu arteritis |
| TBR | Target-to-blood pool ratio |
| TNF | Tumor necrosis factor |
| TIMP-1 | Tissue inhibitor of metalloproteinases 1 |
| VCAM-1 | Vascular cell adhesion molecule 1 |
| VDI | Vasculitis Damage Index |
| VEGF | Vascular endothelial growth factor |